Precision and Progression: India's Role in Cardiac Care Innovation
The evolution of cardiac care over the last 50 years has transformed treatment with precision-driven innovations. The PRISM-PCI Conclave 2026 in India highlighted how angioplasty has evolved, reflecting broader medical advances. India's growing role in global cardiac innovation was underscored, demonstrating advancements in technology and patient outcomes.
Cardiac care has dramatically evolved over the past five decades, beginning with the 1977 balloon angioplasty to today’s precision-guided interventions. This development journey mirrors the broader evolution of medicine, aiming for safer, more personalized patient treatments as seen at the PRISM-PCI Conclave 2026 in India.
Hosted by Meril Life Sciences, the event gathered 300 interventional cardiologists globally to examine the increasing complexity of angioplasty procedures. India's pivotal role as a global medical technology hub was highlighted, showcasing the country's move from merely consuming innovations to becoming a significant contributor.
Speakers emphasized India’s growing influence in cardiac care innovation. Dr. Ashok Seth lauded India’s transition to a key player in technology innovation in cardiovascular disease management, and Dr. Samin Sharma emphasized precision in angioplasty. PRISM-PCI highlighted prevention as essential, stressing the importance of detection and lifestyle changes to combat heart disease in younger populations.
ALSO READ
-
Empowering Rural India: Community Mediation for Dispute Resolution
-
Revolutionizing Energy: The AI and Renewable Energy Convergence in India
-
Chaos at India's AI Impact Summit: Promises and Pitfalls
-
Rahul Gandhi Championing Gig Workers' Rights in India
-
AI Revolution: India and UK Poised for Global Leadership